← All Maze Therapeutics, INC filings

Maze Therapeutics, INC Form 4 insider transactions

NASDAQ
MAZE
Maze Therapeutics, INC
Form 4: Maze Therapeutics Director Homcy Charles J Reports Beneficial Ownership Changes
Director Charles J. Homcy reports changes in beneficial ownership of Maze Therapeutics stock and derivative securities following the company's IPO and related conversions.